US 9526777
Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein
granted A61KA61K2039/5254A61K2039/5256
Quick answer
US patent 9526777 (Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/5254, A61K2039/5256, A61K2039/545, A61K39/12